Studies related to Proteinuria and Benfotiamine

Effect Of Benfotiamine On Advanced Glycation Endproducts And Markers Of Endothelial Dysfunction And Inflammation In Diabetic Nephropathy

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 82
Sex Both Genders
Age Range 45-64, 65+
Body Types Obese
Notes for this study:
900mg (3x300mg) Benfotiamine daily for 12 weeks in diabetics with moderate-high levels of urinary albumin failed to reduce serum or urinary AGEs in a trial where diet was not controlled.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.